Login / Register The Most Trusted Name in Medical Education

ASCO & ESMO 2017 Highlights: Incorporating Immuno-oncology Agents into Solid and Liquid Tumor Treatment Paradigms

ASCO & ESMO 2017 Highlights: Incorporating Immuno-oncology Agents into Solid and Liquid Tumor Treatment Paradigms

Format: Webcast
Credits: Earn up to 2.0 AMA PRA Category 1 Credit(s)™

 The goal of this initiative is to help medical oncology and hematology-oncology physicians and advanced practitioners in community and academic settings to integrate checkpoint inhibitors into cancer treatment regimens and understand their unique safety and response profiles.

Take Courses »